Evotec SE and biotech venture capital firm Claris Ventures have announced an acceleration framework to streamline programs from Claris’s portfolio companies into the clinic through Evotec’s fully integrated platform.   Claris’s portfolio is focused on biotech companies with programs approaching clinical trials and currently consists of nine biotech companies across Italy, Switzerland, and the UK. Claris provides resources, capabilities, and connections to complete pre-clinical studies and run ...